Susan A. Borosky

1.1k total citations
16 papers, 988 citations indexed

About

Susan A. Borosky is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Susan A. Borosky has authored 16 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Susan A. Borosky's work include Neuroscience and Neuropharmacology Research (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Ion channel regulation and function (3 papers). Susan A. Borosky is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Ion channel regulation and function (3 papers). Susan A. Borosky collaborates with scholars based in United States and Norway. Susan A. Borosky's co-authors include John W. Ferkany, David Dooley, Michael J. Pontecorvo, David B. Clissold, Larry R. Steranka, Jane R. Connor, Donald C. Manning, John M. Stewart, Raymond J. Vavrek and S H Snyder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Susan A. Borosky

16 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan A. Borosky United States 12 552 479 258 190 125 16 988
G.S. Mason United Kingdom 14 565 1.0× 457 1.0× 346 1.3× 92 0.5× 190 1.5× 16 1.1k
Caroline Hicks United Kingdom 24 862 1.6× 627 1.3× 197 0.8× 104 0.5× 43 0.3× 35 1.5k
J.K. Webb United Kingdom 14 529 1.0× 452 0.9× 454 1.8× 100 0.5× 118 0.9× 17 1.0k
Véronique Sazdovitch France 19 375 0.7× 784 1.6× 454 1.8× 132 0.7× 85 0.7× 34 1.9k
Gary Pastor Switzerland 12 532 1.0× 308 0.6× 120 0.5× 68 0.4× 60 0.5× 15 814
Francesca Vaglini Italy 17 529 1.0× 477 1.0× 135 0.5× 63 0.3× 44 0.4× 72 1.2k
S. S. Jossan Sweden 17 347 0.6× 255 0.5× 215 0.8× 69 0.4× 51 0.4× 26 820
Char‐Chang Shieh United States 20 707 1.3× 1.2k 2.5× 361 1.4× 53 0.3× 55 0.4× 29 1.8k
Franćoise Lejeune France 21 881 1.6× 623 1.3× 102 0.4× 75 0.4× 125 1.0× 33 1.3k
Jeffery D. Rothstein United States 12 294 0.5× 364 0.8× 267 1.0× 286 1.5× 45 0.4× 14 1.0k

Countries citing papers authored by Susan A. Borosky

Since Specialization
Citations

This map shows the geographic impact of Susan A. Borosky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan A. Borosky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan A. Borosky more than expected).

Fields of papers citing papers by Susan A. Borosky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan A. Borosky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan A. Borosky. The network helps show where Susan A. Borosky may publish in the future.

Co-authorship network of co-authors of Susan A. Borosky

This figure shows the co-authorship network connecting the top 25 collaborators of Susan A. Borosky. A scholar is included among the top collaborators of Susan A. Borosky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan A. Borosky. Susan A. Borosky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dounay, Amy B., Nancy S. Barta, Jack Bikker, et al.. (2008). Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(4). 1159–1163. 10 indexed citations
2.
Dooley, David, et al.. (2000). Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neuroscience Letters. 280(2). 107–110. 196 indexed citations
4.
Bigge, Christopher F., et al.. (1995). Potent, Orally Active, Competitive N-Methyl-D-aspartate (NMDA) Receptor Antagonists Are Substrates for a Neutral Amino Acid Uptake System in Chinese Hamster Ovary Cells. Journal of Medicinal Chemistry. 38(11). 1955–1965. 20 indexed citations
5.
Hamilton, Gregory S., David Bednář, Susan A. Borosky, et al.. (1994). Synthesis and glutamate antagonist activity of 4-phosphonoalkylquinoline derivatives: A novel class of non-NMDA antagonist. Bioorganic & Medicinal Chemistry Letters. 4(16). 2035–2040. 4 indexed citations
6.
Clissold, David B., Michael J. Pontecorvo, M E Abreu, et al.. (1993). NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 876–886. 21 indexed citations
7.
Ferkany, John W., Gregory S. Hamilton, Raymond J. Patch, et al.. (1993). Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 256–264. 27 indexed citations
8.
Karbon, E. William, M E Abreu, David B. Clissold, et al.. (1993). NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 866–875. 23 indexed citations
9.
Hamilton, Gregory S., Zhi Huang, Raymond J. Patch, et al.. (1992). Phosphonoethylphenylalanine derivatives as novel antagonists of non-NMDA ionotropic glutamate receptors. Bioorganic & Medicinal Chemistry Letters. 2(10). 1269–1274. 3 indexed citations
10.
Pontecorvo, Michael J., E. William Karbon, David B. Clissold, et al.. (1991). Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Research Bulletin. 26(3). 461–465. 60 indexed citations
11.
Ferkany, John W., Donald J. Kyle, Jonathon M. Willets, et al.. (1989). Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 100–109. 74 indexed citations
12.
Ferkany, John W., Susan A. Borosky, David B. Clissold, & Michael J. Pontecorvo. (1988). Dextromethorphan inhibits NMDA-induced convulsions. European Journal of Pharmacology. 151(1). 151–154. 113 indexed citations
13.
Steranka, Larry R., Donald C. Manning, John W. Ferkany, et al.. (1988). Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.. Proceedings of the National Academy of Sciences. 85(9). 3245–3249. 334 indexed citations
14.
Cooper, Cary W., Susan A. Borosky, Patrick E. Farrell, & Odd S. Steinsland. (1986). Effects of the Calcium Channel Activator BAY-K-8644 onin VitroSecretion of Calcitonin and Parathyroid Hormone*. Endocrinology. 118(2). 545–549. 32 indexed citations
15.
Cooper, Cary W. & Susan A. Borosky. (1986). Inhibition of secretion of rat calcitonin by calmodulin inhibitors. Calcified Tissue International. 38(2). 103–108. 8 indexed citations
16.
Cooper, Cary W., Susan A. Borosky, & Tao Peng. (1985). Secretion of Calcitonin Gene-Related Peptide from Baby Rat Thyroid Glands in Vitro. Experimental Biology and Medicine. 180(3). 562–566. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026